Abstract: A high prevalence of the
rtI187V polymerase substitution of hepatitis B virus (HBV) was detected in nucleoside/nucleotide-analogue-naive and -treated
chronic hepatitis B (
CHB) patients.
Abstract: Furthermore,
rtI187V HBV remained susceptible towards treatment with LAM or ADV in vitro whereas the combination of the
rtI187V substitution with LAM-resistant mutations rendered HBV resistant to LAM but still sensitive to ADV.
Abstract: However, the emergence of the
rtI187V substitution significantly impaired viral replication but without affecting drug sens